News

Partial screen grab of the December 2021 issue of the CP-CTNet Newsletter.

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).
POSTED: 12/22/2021
Thank You--50th Anniversary of the National Cancer Act
Fifty years ago this week, the National Cancer Act was signed into law, kick-starting research that has changed how cancer is prevented, detected, diagnosed, treated, and survived, and moving us closer to a time when no one… Learn more
POSTED: 12/20/2021
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
An older woman with a handful of oral medications.
For older adults undergoing treatment for advanced cancer, results from a clinical trial show that a health measurement tool called a geriatric assessment can be an important part of treatment planning. In the trial, older… Learn more
POSTED: 12/15/2021
An illustration displaying possible inherited risk carriers within a family.
If your family member had cancer, would you want to know if you carried a gene mutation that increased your risk of the same cancer? This question is at the heart of three novel research projects underway to determine how… Learn more
POSTED: 11/29/2021
The NCI Community Oncology Research Program (NCORP) annual meeting for grantees in August 2021 virtually brought together representatives from every NCORP Research Base and Community and Minority Underserved Site to discuss… Learn more
POSTED: 11/10/2021
Screen capture of the Fall 2021 issue the CP-CTNet Newsletter.
The first day of autumn was September 22nd. Fall reminds us that change can be a beautiful process. It’s the season that conjures up memories of heading back to school, visits to the pumpkin patch, jumping in piles of… Learn more
POSTED: 10/12/2021
Estimated cases of myelodysplastic syndrome cases in the US each year.
In a clinical study underway, scientists hope to unravel the complexities of a group of poorly understood and relatively rare blood disorders that often lead to cancer. In myelodysplastic syndromes (MDS), the problem arises… Learn more
POSTED: 10/5/2021
AUTHOR: Susan Jenks
NCI graphic showing checked off text boxes
A year ago, I said that coming on board as the Division of Cancer Prevention Director in July 2020 was a “challenge,” adding that I had faith in science that the pandemic would be solved soon. Science has brought us a… Learn more
POSTED: 9/20/2021
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
none
In this issue, we feature: ULACNet-101 Getting Ready for Recruitment, ROCCHHA Opens Enrollment in Puerto Rico and Brazil for ULACNet-201, and an interview with Dr. Lenka Kolevic. Translations are available in Spanish and… Learn more
POSTED: 9/20/2021
40% of women who inherit a mutation in their BRCA1 gene will develop ovarian cancer in their lifetime.
Researchers in gynecologic oncology have begun testing a promising surgery for premenopausal women at high genetic risk for ovarian cancer that avoids early menopause and may prevent these malignancies from developing.… Learn more
POSTED: 9/7/2021
AUTHOR: Susan Jenks
Leaders in NCI's Division of Cancer Prevention: Dr. Philip Castle, Director and Dr. Lori Minasian, Deputy Director.
This Healthcast podcast commemorates the National Cancer Act's 50th anniversary by highlighting the progress the National Cancer Institute has made in cancer prevention. Leaders in NCI's Division of Cancer… Learn more
POSTED: 8/31/2021
STAT First Opinion
In 2020, a year of unimaginable tragedy, an estimated 375,000 people died from Covid-19 infections in the United States alone. Much of the suffering and death due to the disease was preventable in three ways: through… Learn more
POSTED: 8/9/2021
A young adult using a smartphone.
Being a teenager or young adult is hard enough. Add a cancer diagnosis, and the challenges—which can range from severe fatigue to financial stress—are likely to multiply.
POSTED: 8/4/2021
Cancer Prevention word cloud with the science's keywords.

Philip Castle, Ph.D., M.P.H., joined NCI in July 2020 as director of the Division of Cancer Prevention (DCP). Dr. Castle previously worked at NCI in the Division of Cancer Epidemiology and Genetics (2002–2010),… Learn more
POSTED: 7/20/2021
Image of needle injecting vaccine in arm.
One of the first-ever vaccines for the prevention of colorectal and other cancers in patients at high genetic risk for these malignancies is expected to start its early phase safety and immunogenicity trial in the first… Learn more
POSTED: 7/13/2021
AUTHOR: Susan Jenks
Bob Aronson was only 54 years old and, in the words of his son Tom, “extremely healthy.”

“So it was really surprising to everyone when he went in for an annual routine eye exam and his eye doctor suspected… Learn more
POSTED: 7/7/2021
2019 Group photo of the CPFP Fellows.
Preventing cancer today and in the future lies at the heart of the National Cancer Institute’s competitive postdoctoral fellowship program, which is accepting candidate applications for the 2022 class until August 16, 2021.
POSTED: 5/25/2021
AUTHOR: Susan Jenks